⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

TWST

Twist Bioscience Corporation

Healthcare · Biotechnology

125.52USD

-2.5400 (-1.98%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End09/2025
Last Quarter End06/2026 Q3
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 125.52
P/E—
Dvd Ind Yld—
P/B17.66
P/S18.2
Curr EV/T12M EBITDA-69.2
Mkt Cap (USD)7.9B
Curr EV (USD)8.0B
2)

Per Share Data

EPS T12M-2.22
DPS—
Bk Val Per Sh7.11
Rev/Sh6.92
Cash/Sh2.66
Curr Shares Out62.7M
FCF/Sh-1.49
3)

Cash Flow Analysis

P/CF-148.3
Curr P/FCF-84.5
CF/NI0.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-12.3%
Eff Interest Rate16.6%
4)

Growth Potential

Dil EPS 1Y Gr63.9%
Cap 1Y Gr0.1%
BPS 1Y Gr-2.9%
R&D To Sales16.6%
Retention Rate100.0%
Rev 1Y Gr20.3%
FCF 1Y Gr-9.3%
Assets 1Y Gr4.5%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-33.6%
Pretax Margin-31.5%
Net Margin-31.7%
ROA-20.8%
ROE-29.6%
ROC—
Asset Turnover0.66
6)

Structure

Current Ratio2.67
Quick Ratio1.98
Debt/Assets0.1%
Debt/Com Eq0.1%
Net Debt/EBITDA0.97
Tot Debt/Capital0.1%
Gross Margin52.0%
EBIT/Int Exp-739.7

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.